BRAF(V600) mutation levels predict response to vemurafenib in metastatic melanoma.
作者信息
Lebbé Celeste, How-Kit Alexandre, Battistella Maxime, Sadoux Aurelie, Podgorniak Marie-Pierre, Sidina Irina, Pages Cécile, Roux Jennifer, Porcher Raphael, Tost Jorg, Mourah Samia
机构信息
aAP-HP, Department of Dermatology, Saint-Louis Hospital bParis-Diderot University, Sorbonne Paris Cite cINSERM U976 dLaboratory for Functional Genomics, Jean Dausset Fondation - CEPH eAP-HP, Pathology Laboratory, Saint-Louis Hospital, INSERM UMR_S 1165 fAP-HP, Saint-Louis Hospital, Pharmacology-Genetic Laboratory gDepartment of Biostatistics and Medical Data Processing, INSERM-U717 hLaboratory for Epigenetics and Environment, Genotyping National Center, CEA, Genomic Institute iINSERM UMR-S 940, Paris, France.
出版信息
Melanoma Res. 2014 Aug;24(4):415-8. doi: 10.1097/CMR.0000000000000088.
Zotero 插件